1,3-Dihydro1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-5-chloro-2H-benzimidazol-2-one;R-29764;2H-Benzimidazol-2-one, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-5-chloro-1,3-dihydro-;NSC 335305;NSC335305;NSC-335305;Clopimozide, 10 mM in DMSO
Clopimozide is an orally active antipsychotic agent used in the research of both negative and positive symptoms of schizophrenia; it acts as a calcium channel antagonist with an IC50 of 17 nM for inhibition of [3H]nitrendipine binding.